|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
Taysha Gene Therapies, Inc. (TSHA) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
Company
Roster
|
Total
Insiders : |
9 |
|
|
Total
Direct Shares :
|
22,399,010 |
|
Total
Indirect Shares :
|
26,219,793 |
|
%
Held by Insiders:
|
11.98% |
|
|
|
Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Session R.a. Ii |
|
2023-07-13 |
8,871,747 |
2023-07-13 |
282,180 |
Alam Kamran |
|
2024-02-02 |
840,937 |
2020-09-23 |
0 |
Stalfort Sean |
|
2024-05-29 |
1,098,601 |
2024-05-29 |
884,290 |
Long Alison S |
|
2024-05-29 |
49,220 |
2024-05-29 |
0 |
Donenberg Philip B |
|
2024-05-29 |
163,331 |
2022-02-02 |
0 |
Sepp-Lorenzino Laura |
|
2024-05-29 |
49,220 |
2024-05-29 |
0 |
Astellas Pharma Inc. |
10% Owner |
2022-10-21 |
7,266,342 |
|
0 |
Manning Paul B |
10% Owner |
2022-10-31 |
1,642,202 |
2023-11-17 |
23,517,778 |
Nolan Sean P. |
Chief Executive Officer, Director |
2024-01-02 |
1,185,858 |
2024-01-02 |
1,535,545 |
Prasad Suyash |
CMO and Head of R&D |
2022-07-06 |
530,589 |
2020-09-23 |
0 |
Nagendran Sukumar |
President and Head of R&D, Director |
2024-01-02 |
897,843 |
2020-09-28 |
0 |
|
|